These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35128832)

  • 1. Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis.
    Zeybel M; Arif M; Li X; Altay O; Yang H; Shi M; Akyildiz M; Saglam B; Gonenli MG; Yigit B; Ulukan B; Ural D; Shoaie S; Turkez H; Nielsen J; Zhang C; Uhlén M; Borén J; Mardinoglu A
    Adv Sci (Weinh); 2022 Apr; 9(11):e2104373. PubMed ID: 35128832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease.
    Kong G; Ellul S; Narayana VK; Kanojia K; Ha HTT; Li S; Renoir T; Cao KL; Hannan AJ
    Neurobiol Dis; 2021 Jan; 148():105199. PubMed ID: 33249136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the early life gut microbiome in neonates with critical congenital heart disease: multiomics insights and implications for host metabolic and immunological health.
    Huang Y; Lu W; Zeng M; Hu X; Su Z; Liu Y; Liu Z; Yuan J; Li L; Zhang X; Huang L; Hu W; Wang X; Li S; Zhang H
    Microbiome; 2022 Dec; 10(1):245. PubMed ID: 36581858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome.
    Abenavoli L; Scarlata GGM; Scarpellini E; Boccuto L; Spagnuolo R; Tilocca B; Roncada P; Luzza F
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses.
    Kunath BJ; Hickl O; Queirós P; Martin-Gallausiaux C; Lebrun LA; Halder R; Laczny CC; Schmidt TSB; Hayward MR; Becher D; Heintz-Buschart A; de Beaufort C; Bork P; May P; Wilmes P
    Microbiome; 2022 Dec; 10(1):243. PubMed ID: 36578059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome.
    Mayneris-Perxachs J; Cardellini M; Hoyles L; Latorre J; Davato F; Moreno-Navarrete JM; Arnoriaga-Rodríguez M; Serino M; Abbott J; Barton RH; Puig J; Fernández-Real X; Ricart W; Tomlinson C; Woodbridge M; Gentileschi P; Butcher SA; Holmes E; Nicholson JK; Pérez-Brocal V; Moya A; Clain DM; Burcelin R; Dumas ME; Federici M; Fernández-Real JM
    Microbiome; 2021 May; 9(1):104. PubMed ID: 33962692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomics analyses reveal dose-dependent effects of dicofol exposure on host metabolic homeostasis and the gut microbiota in mice.
    Wei S; Ye X; Lei H; Cao Z; Chen C; Zhang C; Zhang L; Chen C; Liu X; Zhang L; Chen X
    Chemosphere; 2023 Nov; 341():139997. PubMed ID: 37648173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different hypercaloric diets on obesity features in rats: a metagenomics and metabolomics integrative approach.
    Gual-Grau A; Guirro M; Mayneris-Perxachs J; Arola L; Boqué N
    J Nutr Biochem; 2019 Sep; 71():122-131. PubMed ID: 31336215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.
    Niu C; Tu Y; Jin Q; Chen Z; Yuan K; Wang M; Zhang P; Luo J; Li H; Yang Y; Liu X; Mao M; Dong T; Tan W; Hu X; Pan Y; Hou L; Ma R; Huang Z
    Front Cell Infect Microbiol; 2023; 13():1157368. PubMed ID: 37180439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbial Perturbation and Host Response Induce Redox Pathway Upregulation along the Gut-Liver Axis during Giardiasis in C57BL/6J Mouse Model.
    Karpe AV; Hutton ML; Mileto SJ; James ML; Evans C; Ghodke AB; Shah RM; Metcalfe SS; Liu JW; Walsh T; Lyras D; Palombo EA; Beale DJ
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human gut microbiome and its dysfunctions through the meta-omics prism.
    Mondot S; Lepage P
    Ann N Y Acad Sci; 2016 May; 1372(1):9-19. PubMed ID: 26945826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics.
    Nuli R; Azhati J; Cai J; Kadeer A; Zhang B; Mohemaiti P
    J Diabetes Res; 2019; 2019():2893041. PubMed ID: 31828159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.
    Tian R; Liu H; Feng S; Wang H; Wang Y; Wang Y; Liang L; Xu H; Xing H; Zhang S
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1454-1466. PubMed ID: 33810955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
    Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
    Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumption of Wild Rice (
    Hou XD; Yan N; Du YM; Liang H; Zhang ZF; Yuan XL
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.
    Jennison E; Byrne CD
    Clin Mol Hepatol; 2021 Jan; 27(1):22-43. PubMed ID: 33291863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics insights into the interplay between gut microbiota and colorectal cancer in the "microworld" age.
    Wang AJ; Song D; Hong YM; Liu NN
    Mol Omics; 2023 May; 19(4):283-296. PubMed ID: 36916422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
    Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
    PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis.
    Rao Y; Kuang Z; Li C; Guo S; Xu Y; Zhao D; Hu Y; Song B; Jiang Z; Ge Z; Liu X; Li C; Chen S; Ye J; Huang Z; Lu Y
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 34030573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.